NO990304L - Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer - Google Patents

Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer

Info

Publication number: NO990304L
Authority: NO; Norway
Prior art keywords: ligands; pyridazole; derivatives; substituted triazole; substituted
Prior art date: 1996-07-25

Application number

NO990304A

Other languages

English (en)

Norwegian (no)

Other versions

NO990304D0 (no

Inventor

Howard Barff Broughton

William Robert Carling

Jose Luis Castro Pineiro

Alexander Richard Guiblin

Andrew Madin

Kevin William Moore

Michael Geoffrey Russell

Leslie Joseph Street

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-25

Filing date

1999-01-22

Publication date

1999-03-25

1996-07-25 Priority claimed from GBGB9615645.0A external-priority patent/GB9615645D0/en

1996-12-06 Priority claimed from GBGB9625397.6A external-priority patent/GB9625397D0/en

1997-07-09 Priority claimed from GBGB9714420.8A external-priority patent/GB9714420D0/en

1999-01-22 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

1999-01-22 Publication of NO990304D0 publication Critical patent/NO990304D0/no

1999-03-25 Publication of NO990304L publication Critical patent/NO990304L/no

Links

239000003446 ligand Substances 0.000 title abstract 2
102000005915 GABA Receptors Human genes 0.000 title 1
108010005551 GABA Receptors Proteins 0.000 title 1
208000019901 Anxiety disease Diseases 0.000 abstract 1
102000027484 GABAA receptors Human genes 0.000 abstract 1
108091008681 GABAA receptors Proteins 0.000 abstract 1
208000007101 Muscle Cramp Diseases 0.000 abstract 1
YRACHDVMKITFAZ-UHFFFAOYSA-N [1,2,4]triazolo[4,3-b]pyridazine Chemical class C1=CC=NN2C=NN=C21 YRACHDVMKITFAZ-UHFFFAOYSA-N 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
208000015114 central nervous system disease Diseases 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO990304A 1996-07-25 1999-01-22 Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer NO990304L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9615645.0A GB9615645D0 (en)	1996-07-25	1996-07-25	Therapeutic agents
GBGB9625397.6A GB9625397D0 (en)	1996-12-06	1996-12-06	Therapeutic agents
GBGB9714420.8A GB9714420D0 (en)	1997-07-09	1997-07-09	Therapeutic agents
PCT/GB1997/001946 WO1998004559A2 (en)	1996-07-25	1997-07-17	Substituted triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (2)

Publication Number	Publication Date
NO990304D0 NO990304D0 (no)	1999-01-22
NO990304L true NO990304L (no)	1999-03-25

Family

ID=27268403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO990304A NO990304L (no)	1996-07-25	1999-01-22	Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer

Country Status (24)

Country	Link
US (1)	US6255305B1 (de)
EP (1)	EP0915875B1 (de)
JP (1)	JP4216905B2 (de)
KR (1)	KR20000029548A (de)
CN (1)	CN1251589A (de)
AT (1)	ATE236904T1 (de)
AU (1)	AU723098B2 (de)
BG (1)	BG103112A (de)
BR (1)	BR9710729A (de)
CZ (1)	CZ18199A3 (de)
DE (1)	DE69720732T2 (de)
EA (1)	EA002436B1 (de)
EE (1)	EE9900027A (de)
ES (1)	ES2194205T3 (de)
HU (1)	HUP0600527A2 (de)
IL (1)	IL127911A0 (de)
IS (1)	IS4949A (de)
NO (1)	NO990304L (de)
NZ (1)	NZ333768A (de)
PL (1)	PL331072A1 (de)
SK (1)	SK9399A3 (de)
TR (1)	TR199900047T2 (de)
WO (1)	WO1998004559A2 (de)
YU (1)	YU2899A (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2288789C (en) *	1997-05-08	2009-07-21	Merck Sharp & Dohme Limited	Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
GB9715977D0 (en) *	1997-07-29	1997-10-01	Merck Sharp & Dohme	Therapeutic agents
US6297235B1 (en) *	1997-08-28	2001-10-02	Merck Sharp & Dohme Ltd.	Triazolopyridazine derivatives for treating anxiety and enhancing cognition
GB9718254D0 (en)	1997-08-28	1997-11-05	Merck Sharp & Dohme	Therapeutic agents
GB9723999D0 (en)	1997-11-13	1998-01-14	Merck Sharp & Dohme	Therapeutic use
GB9726701D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use
GB9726702D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use
GB9726699D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use
WO1999025353A1 (en) *	1997-11-13	1999-05-27	Merck Sharp & Dohme Limited	Therapeutic uses of triazolo-pyridazine derivatives
US6110915A (en) *	1997-12-18	2000-08-29	Merck & Co., Inc.	Antiemetic use of triazolo-pyridazine derivatives
CA2315219A1 (en)	1998-01-14	1999-07-22	Merck Sharp & Dohme Limited	Triazolo-pyridazine derivatives as ligands for gaba receptors
HUP0100575A3 (en) *	1998-01-21	2003-03-28	Merck Sharp & Dohme Ltd Hoddes	Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801210D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801202D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801234D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801208D0 (en) *	1998-01-21	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801397D0 (en)	1998-01-22	1998-03-18	Merck Sharp & Dohme	Therapeutic agents
GB9801538D0 (en)	1998-01-23	1998-03-25	Merck Sharp & Dohme	Pharmaceutical product
EP1087968A1 (de) *	1998-06-16	2001-04-04	MERCK SHARP & DOHME LTD.	Triazolo-pyridin-derivate als liganden für gabarezeptoren
GB9813006D0 (en) *	1998-06-16	1998-08-12	Merck Sharp & Dohme	Therapeutic agents
GB9813576D0 (en)	1998-06-24	1998-08-19	Merck Sharp & Dohme	Therapeutic agents
GB9821179D0 (en) *	1998-09-30	1998-11-25	Merck Sharp & Dohme	Therapeutic use
CA2346659A1 (en) *	1998-10-06	2000-04-13	Michiyo Gyoten	Condensed pyridazine compounds, their production and use
ATE371659T1 (de) *	1998-10-16	2007-09-15	Merck Sharp & Dohme	Pyrazolotriazinderivate als gaba-rezeptorliganden
IT1303272B1 (it) *	1998-10-29	2000-11-06	Zambon Spa	Derivati triciclici inibitori della fosfodiesterasi 4
GB9824897D0 (en) *	1998-11-12	1999-01-06	Merck Sharp & Dohme	Therapeutic compounds
GB2345443A (en) *	1999-01-08	2000-07-12	Merck Sharp & Dohme	Use of triazolo-pyridazines for treating premenstrual syndrome
ATE284403T1 (de) *	1999-01-27	2004-12-15	Merck Sharp & Dohme	Triazolopyridazinderivate als liganden für gaba- rezeptoren
GB9903119D0 (en) *	1999-02-11	1999-04-07	Merck Sharp & Dohme	Therapeutic agents
US6737242B1 (en)	1999-05-07	2004-05-18	Neurogen Corporation	Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9919957D0 (en) *	1999-08-23	1999-10-27	Merck Sharp & Dohme	Therapeutic agents
GB9921351D0 (en)	1999-09-09	1999-11-10	Merck Sharp & Dohme	Therapeutic agents
US6355638B1 (en) *	1999-11-25	2002-03-12	Merck Sharp & Dohme Ltd.	Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
GB9929569D0 (en)	1999-12-14	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
GB9929685D0 (en) *	1999-12-15	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
GB9929687D0 (en) *	1999-12-15	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
GB0000564D0 (en) *	2000-01-11	2000-03-01	Merck Sharp & Dohme	Therapeutic agents
GB0008696D0 (en)	2000-04-07	2000-05-31	Merck Sharp & Dohme	Therapeutic agents
GB0017518D0 (en) *	2000-07-17	2000-08-30	Merck Sharp & Dohme	Therapeutic agents
GB0018473D0 (en)	2000-07-27	2000-09-13	Merck Sharp & Dohme	Therapeutic agents
GB0028583D0 (en)	2000-11-23	2001-01-10	Merck Sharp & Dohme	Therapeutic compounds
GB0108475D0 (en) *	2001-04-04	2001-05-23	Merck Sharp & Dohme	New compounds
WO2002083139A1 (en)	2001-04-10	2002-10-24	Merck & Co., Inc.	Inhibitors of akt activity
US6958334B2 (en)	2001-04-10	2005-10-25	Merck & Co., Inc.	Inhibitors of Akt activity
US6960584B2 (en)	2001-04-10	2005-11-01	Merck & Co., Inc.	Inhibitors of Akt activity
US20040106540A1 (en) *	2001-04-10	2004-06-03	Barnett Stanley F	Method of treating cancer
GB0122696D0 (en)	2001-09-20	2001-11-14	Merck Sharp & Dohme	Therapeutic agents
GB0128499D0 (en) *	2001-11-28	2002-01-23	Merck Sharp & Dohme	Therapeutic agents
EP1496981A2 (de) *	2002-04-08	2005-01-19	Merck & Co., Inc.	Verfahren zur behandlung von krebs
US20060235021A1 (en) *	2002-08-13	2006-10-19	Wesley Blackaby	Phenylpyridazine derivatives as ligands for gaba receptors
GB0218876D0 (en) *	2002-08-13	2002-09-25	Merck Sharp & Dohme	Therapeutic agents
WO2004058769A2 (en)	2002-12-18	2004-07-15	Vertex Pharmaceuticals Incorporated	Triazolopyridazines as protein kinases inhibitors
DK1697371T3 (da) *	2003-12-19	2007-09-17	Bristol Myers Squibb Co	Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
KR101368093B1 (ko)	2004-09-02	2014-03-14	다케다 게엠베하	트리아졸로프탈라진
WO2006061428A2 (en) *	2004-12-10	2006-06-15	Universität Zürich	Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
CN101103033B (zh)	2005-01-05	2010-08-04	尼科梅德有限责任公司	作为pde2抑制剂的三唑并酞嗪
CA2591991C (en)	2005-01-05	2013-11-19	Altana Pharma Ag	Triazolophthalazines
US7572807B2 (en)	2005-06-09	2009-08-11	Bristol-Myers Squibb Company	Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
EP2258358A3 (de)	2005-08-26	2011-09-07	Braincells, Inc.	Neurogenese mit Acetylcholinesterasehemmer
EP2275095A3 (de)	2005-08-26	2011-08-17	Braincells, Inc.	Neurogenese durch modulation des Muscarinrezeptors
EP1940389A2 (de)	2005-10-21	2008-07-09	Braincells, Inc.	Modulation von neurogenese durch pde-hemmung
AU2006308889A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
JP2009536667A (ja)	2006-05-09	2009-10-15	ブレインセルス，インコーポレイティド	５ｈｔ受容体介在性の神経新生
EP2382975A3 (de)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenese mittels Angiotensin-Modulation
AU2007292848A1 (en)	2006-09-08	2008-03-13	Braincells, Inc.	Combinations containing a 4-acylaminopyridine derivative
US7638541B2 (en)	2006-12-28	2009-12-29	Metabolex Inc.	5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
AU2008279447A1 (en) *	2007-07-19	2009-01-29	Metabolex, Inc.	N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
WO2009123537A1 (en) *	2008-04-04	2009-10-08	Forskarpatent I Syd Ab	GABAa RECEPTOR MODULATORS
CN104098578A (zh) *	2008-08-29	2014-10-15	康瑟特制药公司	取代的三唑并哒嗪衍生物
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
JP2012531419A (ja)	2009-06-23	2012-12-10	コンサートファーマシューティカルズインコーポレイテッド	Ｇａｂａ−ａ受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
JP5909185B2 (ja)	2009-10-01	2016-04-26	シマベイセラピューティクス，インコーポレーテッド	置換テトラゾール−１−イルフェノキシメチルチアゾール−２−イルピペリジニルピリミジン塩
WO2011047315A1 (en)	2009-10-15	2011-04-21	Concert Pharmaceuticals, Inc.	Subsitituted benzimidazoles
PH12012501361A1 (en)	2009-12-31	2012-10-22	Centro Nac De Investigaciones Oncologicas Cnio	Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en)	2011-01-18	2012-07-26	Centro Nacional De Investigaciones Oncológicas (Cnio)	6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005041A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncológicas (Cnio)	Tricyclic heterocyclic compounds as kinase inhibitors
WO2013004984A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncologicas (Cnio)	Tricyclic compounds for use as kinase inhibitors
WO2013005057A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncológicas (Cnio)	New compounds
CN104768554B (zh) *	2012-11-07	2018-04-17	霍夫曼-拉罗奇有限公司	三唑并化合物
WO2017129801A1 (en)	2016-01-27	2017-08-03	Universität Zürich	Use of gabaa receptor modulators for treatment of itch
CN107344938B (zh) *	2016-05-06	2022-05-06	上海赛默罗生物科技有限公司	吡唑-三嗪类衍生物、其制备方法、药物组合物和用途
CN107344936B (zh) *	2016-05-06	2022-06-03	上海赛默罗生物科技有限公司	三唑哒嗪类衍生物、其制备方法、药物组合物和用途
AU2017305392A1 (en)	2016-08-03	2019-02-21	Cymabay Therapeutics, Inc.	Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
WO2019226820A1 (en)	2018-05-22	2019-11-28	Neurocycle Therapeutics, Inc.	Gabaa positive allosteric modulator compounds for treatment of itch and/ or dermatitis
CN120267677A (zh) *	2019-10-23	2025-07-08	纽罗塞克医疗公司	用gabaa受体调节剂的癫痫状况的治疗
WO2023150377A1 (en) *	2022-02-07	2023-08-10	The Regents Of The University Of Colorado, A Body Corporate	Small molecule cxcr4 agonists, method of synthesis, and method of use
CN120172921A (zh) *	2022-04-15	2025-06-20	内蒙古京科医药科技有限公司	一种1-甲基-1,2,4-三氮唑-3-甲醇及其制备方法
CN114591352B (zh) *	2022-05-11	2022-09-09	上海赛默罗生物科技有限公司	一种三唑并哒嗪类化合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1080712A (en) *	1976-09-22	1980-07-01	Jay D. Albright	Hypotensive agents
PH21834A (en)	1982-01-18	1988-03-17	Lepetit Spa	New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
US4487930A (en)	1982-09-07	1984-12-11	The Dow Chemical Company	6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines
IT1194310B (it)	1983-07-12	1988-09-14	Lepetit Spa	Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US4578464A (en)	1983-11-22	1986-03-25	Merrell Dow Pharmaceuticals Inc.	6-Hydroxyalkylamino-8-methyl-1,2,4-triazolo-[4,3-b]pyridazine and related compounds
FR2562071B1 (fr) *	1984-03-30	1986-12-19	Sanofi Sa	Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
GB9321162D0 (en)	1993-10-13	1993-12-01	Boots Co Plc	Therapeutic agents
GB9507348D0 (en) *	1995-04-08	1995-05-31	Knoll Ag	Therapeutic agents
GB9726702D0 (en) *	1997-12-18	1998-02-18	Merck Sharp & Dohme	Therapeutic use

1997
- 1997-07-17 KR KR1019997000606A patent/KR20000029548A/ko not_active Withdrawn
- 1997-07-17 EE EEP199900027A patent/EE9900027A/xx unknown
- 1997-07-17 JP JP50858598A patent/JP4216905B2/ja not_active Expired - Fee Related
- 1997-07-17 IL IL12791197A patent/IL127911A0/xx unknown
- 1997-07-17 AU AU35539/97A patent/AU723098B2/en not_active Ceased
- 1997-07-17 YU YU2899A patent/YU2899A/sh unknown
- 1997-07-17 ES ES97931960T patent/ES2194205T3/es not_active Expired - Lifetime
- 1997-07-17 DE DE69720732T patent/DE69720732T2/de not_active Expired - Lifetime
- 1997-07-17 HU HU0600527A patent/HUP0600527A2/hu unknown
- 1997-07-17 CN CN97196641A patent/CN1251589A/zh active Pending
- 1997-07-17 TR TR1999/00047T patent/TR199900047T2/xx unknown
- 1997-07-17 CZ CZ99181A patent/CZ18199A3/cs unknown
- 1997-07-17 PL PL97331072A patent/PL331072A1/xx unknown
- 1997-07-17 WO PCT/GB1997/001946 patent/WO1998004559A2/en not_active Ceased
- 1997-07-17 AT AT97931960T patent/ATE236904T1/de not_active IP Right Cessation
- 1997-07-17 NZ NZ333768A patent/NZ333768A/xx unknown
- 1997-07-17 SK SK93-99A patent/SK9399A3/sk unknown
- 1997-07-17 BR BR9710729A patent/BR9710729A/pt unknown
- 1997-07-17 US US09/155,587 patent/US6255305B1/en not_active Expired - Lifetime
- 1997-07-17 EP EP97931960A patent/EP0915875B1/de not_active Expired - Lifetime
- 1997-07-17 EA EA199900164A patent/EA002436B1/ru not_active IP Right Cessation
1999
- 1999-01-19 IS IS4949A patent/IS4949A/is unknown
- 1999-01-22 NO NO990304A patent/NO990304L/no not_active Application Discontinuation
- 1999-01-25 BG BG103112A patent/BG103112A/xx unknown

Also Published As

Publication number	Publication date
BR9710729A (pt)	1999-08-17
CN1251589A (zh)	2000-04-26
US6255305B1 (en)	2001-07-03
NZ333768A (en)	2000-09-29
IL127911A0 (en)	1999-11-30
AU723098B2 (en)	2000-08-17
EE9900027A (et)	1999-08-16
NO990304D0 (no)	1999-01-22
DE69720732T2 (de)	2004-01-29
YU2899A (sh)	2000-03-21
EP0915875B1 (de)	2003-04-09
SK9399A3 (en)	2000-04-10
ES2194205T3 (es)	2003-11-16
TR199900047T2 (xx)	1999-03-22
PL331072A1 (en)	1999-06-21
EP0915875A2 (de)	1999-05-19
EA199900164A1 (ru)	2000-04-24
AU3553997A (en)	1998-02-20
JP2002514169A (ja)	2002-05-14
HUP0600527A2 (en)	2006-11-28
BG103112A (en)	1999-09-30
WO1998004559A2 (en)	1998-02-05
KR20000029548A (ko)	2000-05-25
EA002436B1 (ru)	2002-04-25
JP4216905B2 (ja)	2009-01-28
ATE236904T1 (de)	2003-04-15
DE69720732D1 (de)	2003-05-15
IS4949A (is)	1999-01-19
CZ18199A3 (cs)	1999-06-16

Legal Events

Date	Code	Title	Description
2002-09-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO990304L (no)	1999-03-25	Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer
WO2001038326A3 (en)	2002-05-10	Imidazo-pyridine derivatives as ligands for gaba receptors
BG104671A (en)	2001-05-31	Triazolo-pyridazine derivatives as ligands for gaba receptors
CA2359008A1 (en)	2000-08-03	Triazolo-pyridazine derivatives as ligands for gaba receptors
GB0117277D0 (en)	2001-09-05	Therapeutic agents
WO2002002557A3 (en)	2002-07-18	2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
GB9921150D0 (en)	1999-11-10	Therapeutic agents
BG108166A (en)	2004-09-30	Imidazo-pyrimidine derivatives as liigands for gaba receptors
NO972136D0 (no)	1997-05-09	Fremgangsmåte for fremstilling av uronsyreblokker fra alginat
DK0912564T3 (da)	2003-04-22	Fremgangsmåde til fremstilling af tetrahydroimidazoquinolinaminer.
DK1213969T3 (da)	2004-11-08	Metode til overtrækning af levnedsmidler under anvendelse af hydrogeneret isomaltuloseblanding
TR199901276T2 (xx)	1999-09-21	Farnezil protein transferaz inhibisyonu i�in yararl� bile�ikler.
WO1999057107A3 (en)	2000-02-03	Cannabinoids selective for the cb2 receptor
HUP9903841A2 (hu)	2000-03-28	Eljárás oldatok frakcionálására szimulált mozgóágyas kromatográfiás eljárással
BG105152A (en)	2001-10-31	A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom
ATE253066T1 (de)	2003-11-15	Imidazotriazinderivate als gaba rezeptor-liganden
CA2037116A1 (en)	1991-08-27	Hexahydrobenz ¢cd! indoles
IS4957A (is)	1999-01-26	Hreinsuð prótein, samskeyttar DNA raðir og aðferðir til að stýra þroskun kaffiplantna
DE69726749D1 (de)	2004-01-22	5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
NO994527L (no)	1999-11-18	2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi
HUP9900965A3 (en)	2000-11-28	Process for the preparation of 1-cyclopropyl-3-(substituted phenyl)-propane-1,3-dione derivatives and their intermediates and the intermediates
DK0735043T3 (da)	1998-10-07	Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
TR199700174A2 (tr)	1997-09-21	Asimetrik 4,6-bis(ariloksi)pirimidin bilesiklerinin hazirlanmasi icin proses.
DK1025101T3 (da)	2003-04-07	Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
PE44299A1 (es)	1999-05-06	Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba